A
Power Law company profile
Acerta Pharma
Biotech & Life Sciences · Oss, Netherlands · Founded 2013 Unicorn
Global footprint
Where Acerta Pharma has talent and traffic
AI talent share
2.1%
of workforce is AI talent
(3 of 145 staff)
(3 of 145 staff)
Core AI10.69%
Other AI21.38%
Non-AI workforce14297.93%
Web traffic by country
360
monthly visits
across markets
across markets
🇳🇱 Netherlands111.1%
Patent intelligence
$46M patent portfolio · 27 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$46M
0.66% of valuation · 16.8× smaller than top peer BioNTech ($780M)
27 active patent families
Where Acerta Pharma innovates
Molecular biologyPharmaceutical drugCarcinosisKinase inhibitionProdrug
Above peer median on Legal, Strategic, Market
Quality vs same-sector peers
Acerta Pharma on the five Patsnap quality dimensions
Acerta Pharma in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Acerta Pharma concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Acerta Pharma and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Acerta Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.